about
The spatial distribution of LGR5+ cells correlates with gastric cancer progressionSide population cells as prototype of chemoresistant, tumor-initiating cellsCan nanomedicines kill cancer stem cells?Pericytes, an overlooked player in vascular pathobiologyTrefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.Competing views on cancer.Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors.Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway.A possible explanation for the variable frequencies of cancer stem cells in tumors.Development of adrenal cortex zonation.RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cellsTherapeutic approaches to target cancer stem cells.Autonomous molecular cascades for evaluation of cell surfaces.A quest for initiating cells of head and neck cancer and their treatment.Establishment of Hepatocellular Cancer Induced Pluripotent Stem Cells Using a Reprogramming Technique.Tumor-initiating cells and tumor vascularization.Genes at work in random bouts: stochastically discontinuous gene activity makes cell cycle duration and cell fate decisions variable, thus providing for stem cells plasticity.Complexity of cancer stem cells.Gastric cancer stem cells: therapeutic targets.Therapy-induced enrichment of putative lung cancer stem-like cells.Lung cancer stem cells and implications for future therapeutics.Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.Therapeutic resistance and cancer recurrence mechanisms: Unfolding the story of tumour coming back.Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells.Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells.MicroRNA-34a suppresses cell proliferation and induces apoptosis in U87 glioma stem cells.Telomerase and drug resistance in cancer.Tumor-initiating cells contribute to radiation resistance in primary human renal clear cell carcinomas by activating the DNA damage checkpoint response.Overcoming Multidrug Resistance in Cancer Stem Cells.CBP501 suppresses macrophage induced cancer stem cell like features and metastases.Glioma and glioblastoma - how much do we (not) know?Isolation and characterization of squamous cell carcinoma-derived stem-like cells: role in tumor formation.Cancer stem cells in surgery.Endometrial cytopathology. An image analysis approach using the Ki-67 biomarker.Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.Functional Isolation of Tumor-Initiating Cells using Microfluidic-Based Migration Identifies Phosphatidylserine Decarboxylase as a Key Regulator.
P2860
Q21560986-47D4B5C8-C74E-40A2-84E0-BDED92AABBABQ26823433-21E013F7-0293-4F2F-B833-BC85A9451AADQ27022017-B106E512-0835-4FB3-9B54-8B10BE0BB8DFQ28070053-2C2FF092-4BB3-491D-8FAF-A9EB074A0A86Q33889185-F2E9E291-8126-4F11-9942-81B2AC35F1A2Q34060169-2755079E-21AD-43CF-92F9-7208A6523C58Q34500251-0FFB4BBD-81CA-4141-B6A0-9E93FA53CA36Q34658803-5FC23F76-6CBD-4F05-BA58-C2646F1AFD30Q34946147-21F2E90A-DE2A-46C0-B996-8C941ED0A7A9Q35800278-678525D4-BE9A-4512-8537-CE4D1017159FQ36346959-92AD0163-0DC6-4C44-9C3B-A6FE983C43B3Q37137412-64E05124-ECF3-4B28-8E72-AD2FBAD94C18Q37181257-CF7A4218-EBEF-46A4-9AA7-61E9783F131CQ37334258-C6221A9C-1DC2-43E7-9DEE-22068F1A9B20Q37696049-601F1A26-3D09-4116-B5F0-EED26BD008B1Q37827825-F0BCECDB-A0BB-47C3-907B-601EFC659F13Q37983038-0A1E5FE5-8D2E-4A4A-ACA6-B971C85424A7Q38062506-EB22CCA0-999F-4F92-A179-3F14A6A0598DQ38096903-D0A0A4A7-89AE-429E-AC8B-9FE9B98431A4Q38150766-7BE2C91E-9A54-4BCE-839F-304A0ABFA6D5Q38189297-3785A4D9-BD8D-4FCA-897A-84DFED89B98DQ38818023-04F3DBE7-B034-491D-83A2-4FE22970CC67Q38849650-D92250AA-93B4-4D50-8640-0C6B2BA7342DQ38942907-75CF2F33-2D64-4485-AA71-0FAF4B5AFAA2Q39026693-E55A6FF1-BD25-4111-A0DB-B397532CF39AQ39045018-8114E200-29BB-489C-BD48-0CAAD129014EQ39177284-BE33B042-63D5-4206-B995-00E79506A0EBQ39333491-37574076-478E-4248-B5A0-58BC67780478Q39351996-BC242A9F-3765-43A9-BEE8-608AD7C20E18Q39379394-952FB788-13D3-4155-A827-61393DF559CBQ41618207-2537280E-5449-4D56-9891-8126804134D9Q41771086-919DC5A6-1C8F-4533-AA26-E4CC8D1E06E1Q41873851-4515E435-EEBB-4665-BCA3-6983C43209A3Q42578340-5243B872-A0BA-4A33-997C-368A2DBBB036Q42812684-E762B749-C548-49A0-92B9-469B4D8DBC6FQ43138601-3A4CA219-96ED-4344-8AF6-199CA96A367CQ45939248-209FB42C-2F49-4595-8748-1AB2CAC2F49FQ47117422-A2E3E2C5-40B4-45FF-99CE-7E1DC681EF85Q47118535-3D8D738F-5906-47EE-9442-C5B7BF3CACE3Q48508211-1BE8D2CD-6172-40A0-B359-2922C112B98F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cancer stem cells in solid tumors: elusive or illusive?
@ast
Cancer stem cells in solid tumors: elusive or illusive?
@en
type
label
Cancer stem cells in solid tumors: elusive or illusive?
@ast
Cancer stem cells in solid tumors: elusive or illusive?
@en
prefLabel
Cancer stem cells in solid tumors: elusive or illusive?
@ast
Cancer stem cells in solid tumors: elusive or illusive?
@en
P2860
P356
P1476
Cancer stem cells in solid tumors: elusive or illusive?
@en
P2093
Hans R Lehrach
Yvonne Welte
P2860
P2888
P356
10.1186/1478-811X-8-6
P577
2010-05-11T00:00:00Z
P5875
P6179
1013617721